Endocrinology Search
Endocrinology Endocrinology
obesity
OBESITY
Obesity is having an excessive amount of body fat in relation to lean body mass that may impair health.
The primary cause is an energy imbalance between calories consumed and expended.
Treatment goals include to lose 5-10% of body weight or 0.5-1 kg (1-2 lb)/week for 6 months and regain of <3 kg in 2 years and sustained reduction of waist circumference of at least 4 cm.
Strategies are aiming for realistic goals and a multidisciplinary approach that is a combination of dietary change, physical activity and behavioral modification.
Drug Information

Indication: Adjunctive therapy to diet in patients w/ obesity & BMI ≥30, who have not responded to an appropriate w...

Indication: Short-term adjunct in the management of obesity in a medically monitored comprehensive regimen of wt reduction...

Indication: Iin conjunction w/ a mildly hypocaloric diet for obese (BMI ≥30 kg/m2) & overwt (BMI ≥28 ...

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Obesity protects against diabetic retinopathy in type 2 diabetes
6 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Anastrozole delays bone maturation in kids with congenital adrenal hyperplasia
Yesterday
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
Enzalutamide shows potential survival benefit in metastatic hormone-sensitive prostate cancer
Roshini Claire Anthony, 6 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.
Opioids unlikely to be helpful for long-term management of chronic noncancer pain
6 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.